$69.99 0.00 (0%)
11/24/2008 4:00 PM

ImClone Systems, Inc. (NASDAQ:IMCL.DL)

CAPS Rating: No stars

A biopharmaceutical company which advances oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.

Featured Broker Partners


Advertisement